World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
39259
World Ranking
9954
National Ranking
353

Pietro Invernizzi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pietro Invernizzi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 532 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pietro Invernizzi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pietro Invernizzi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pietro Invernizzi is affiliated with the University of Milano-Bicocca in Italy and has a strong presence in the field of Medicine, particularly focused on liver-related diseases and treatments. Their research spans several subfields including Hepatology, Epidemiology, Surgery, Pulmonary and Respiratory Medicine, and Oncology.

Their work has frequently appeared in prominent publication venues such as:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • Liver International
  • Hepatology
  • Zenodo (CERN European Organization for Nuclear Research)

Invernizzi's main topics of study include:

  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Neuroendocrine Tumor Research Advances
  • Liver Disease and Transplantation

Some of Invernizzi's recent papers include:

  • "Cholangiocarcinoma 2020: the next horizon in mechanisms and management" (2020), published in Nature Reviews Gastroenterology & Hepatology
  • "Genomewide Association Study of Severe Covid-19 with Respiratory Failure" (2020), published in New England Journal of Medicine
  • "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort" (2020), published in Journal of Hepatology
  • "High rates of 30-day mortality in patients with cirrhosis and COVID-19" (2020), published in Journal of Hepatology
  • "Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis" (2023), published in New England Journal of Medicine

Frequent collaborators in their research include:

  • Marco Carbone
  • Alessio Gerussi
  • Laura Cristoferi
  • Nora Cazzagon
  • Sara Massironi

Best Publications

  • EASL Clinical Practice Guidelines: management of cholestatic liver diseases

    Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

    David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti

  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Jesus M. Banales;Jesus M. Banales;Jesus M. Banales;Jose J. G. Marin;Jose J. G. Marin;Angela Lamarca;Angela Lamarca;Pedro M. Rodrigues

  • EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

    Gideon M. Hirschfield;Ulrich Beuers;Christophe Corpechot;Pietro Invernizzi

  • Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    Jesus M. Banales;Vincenzo Cardinale;Guido Carpino;Marco Marzioni

  • A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser

  • Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.

    Juliette Mouries;Paola Brescia;Alessandra Silvestri;Ilaria Spadoni

  • Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆

    Carlo F Selmi;Carlo F Selmi;Marlyn J. Mayo;Nancy Bach;Hiromi Ishibashi

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

    Ulrich H W Beuers;M Eric Gershwin;Robert G Gish;Pietro Luigi Invernizzi

  • Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

    Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy

  • Macrophage plasticity and polarization in liver homeostasis and pathology

    Antonio Sica;Pietro Invernizzi;Alberto Mantovani

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Willem J. Lammers;Gideon M. Hirschfield;Christophe Corpechot;Frederik Nevens

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • The X chromosome and immune associated genes

    Ilaria Bianchi;Ana Lleo;M. Eric Gershwin;Pietro Invernizzi

  • High rates of 30-day mortality in patients with cirrhosis and COVID-19.

    Massimo Iavarone;Roberta D'Ambrosio;Alessandro Soria;Michela Triolo

  • Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort.

    Quentin M. Anstee;Quentin M. Anstee;Rebecca Darlay;Simon Cockell;Marica Meroni

  • Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and ‐negative primary biliary cirrhosis

    P Invernizzi;A Crosignani;P M Battezzati;G Covini

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Carlo Selmi
Carlo Selmi Humanitas University
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Mauro Podda
Mauro Podda University of Cagliari
Ana Lleo
Ana Lleo Humanitas University
Gianfranco Alpini
Gianfranco Alpini Indiana University
Shannon Glaser
Shannon Glaser Texas A&M University
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Domenico Alvaro
Domenico Alvaro Sapienza University of Rome
Albert Parés
Albert Parés University of Barcelona
Aftab A. Ansari
Aftab A. Ansari University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers in the USA, accelerated and flexible online programs can offer a fast track into healthcare professions. Many students look for efficient routes to enhance qualifications or pivot into niche areas, such as nursing leadership or psychiatric care. Options like a 1 year dnp program online allow experienced nurses to achieve a Doctor of Nursing Practice degree quickly, helping them advance into higher-level positions in under a year.

Prospective students may also consider enrolling in the 1 year dnp program online through schools that offer streamlined coursework and flexible schedules. For those starting their nursing journey, a 6 month lpn program online provides a rapid pathway to entering the workforce as a Licensed Practical Nurse.

Additionally, qualified nurses interested in mental health can pursue the fastest post master's pmhnp programs. These programs are designed for speed and flexibility, helping clinicians specialize in psychiatric mental health to meet growing demand.

Best Scientists Citing Pietro Invernizzi

Trending Scientists

Recently Published Articles